Jiang Penglei, Wang Hui, Zheng Jiachen, Han Yingli, Huang He, Qian Pengxu
Center of Stem Cell and Regenerative Medicine, and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P.R. China.
Institute of Hematology, Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Zhejiang University, Hangzhou, P.R. China.
Blood Sci. 2019 Sep 17;1(1):19-28. doi: 10.1097/BS9.0000000000000018. eCollection 2019 Aug.
As one of the best characterized adult stem cells, hematopoietic stem cell (HSC) homeostasis is of great importance to hematopoiesis and immunity due to HSC's abilities of self-renewal and multi-lineage differentiation into functional blood cells. However, excessive self-renewal of HSCs can lead to severe hematopoietic malignancies like leukemia, whereas deficient self-renewal of HSCs may result in HSC exhaustion and eventually apoptosis of specialized cells, giving rise to abnormalities such as immunodeficiency or anemia. How HSC homeostasis is maintained has been studied for decades and regulatory factors can be generally categorized into two classes: genetic factors and epigenetic factors. Although genetic factors such as signaling pathways or transcription factors have been well explored, recent studies have emerged the indispensable roles of epigenetic factors. In this review, we have summarized regulatory mechanisms of HSC homeostasis by epigenetic factors, including DNA methylation, histone modification, chromatin remodeling, non-coding RNAs, and RNA modification, which will facilitate applications such as HSC ex vivo expansion and exploration of novel therapeutic approaches for many hematological diseases.
作为特征最明确的成体干细胞之一,造血干细胞(HSC)的稳态对于造血和免疫至关重要,因为造血干细胞具有自我更新以及多谱系分化为功能性血细胞的能力。然而,造血干细胞的过度自我更新会导致严重的造血系统恶性肿瘤,如白血病,而造血干细胞自我更新不足可能会导致造血干细胞耗竭,并最终导致特化细胞凋亡,从而引发免疫缺陷或贫血等异常情况。几十年来,人们一直在研究造血干细胞的稳态是如何维持的,调控因子通常可分为两类:遗传因素和表观遗传因素。尽管诸如信号通路或转录因子等遗传因素已得到充分研究,但最近的研究表明表观遗传因素也发挥着不可或缺的作用。在这篇综述中,我们总结了表观遗传因素对造血干细胞稳态的调控机制,包括DNA甲基化、组蛋白修饰、染色质重塑、非编码RNA和RNA修饰,这将有助于造血干细胞体外扩增等应用以及探索许多血液系统疾病的新型治疗方法。